title: Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning.
authors.affiliation: Institute of Liver Studies, Division of Transplantation Immunology and Mucosal Biology, King's College, Denmark Hill, London SE5 6FE, UK.
authors.forename: Augusto
authors.initials: A
authors.lastname: Villanueva
authors.affiliation: HCC Translational Research Laboratory, BCLC Group, IDIBAPS, Liver Unit, Hospital Clínic, University of Barcelona and ICREA, Villarroel 170, Barcelona 08036, Spain.
authors.forename: Josep M
authors.initials: JM
authors.lastname: Llovet
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000235:genetics; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D058990:Molecular Targeted Therapy; D009154:Mutation / Q000235:genetics*; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D009363:Neoplasm Proteins